SMART CAMP is addressing key challenges in the manufacture of personalized cell therapies for patients – identifying the critical quality attributes of a cell which contribute to its therapeutic safety and efficacy, and rapidly monitoring and controlling these attributes to improve the ability to manufacture these medicines. Two of SMART CAMP’s Flagship Projects are 1) identifying critical quality attributes for product potency and efficacy in multiple cell types; and 2) developing novel process analytical technologies to assess these attributes. The second Flagship, co-led by Dr. Stacy Springs, is developing novel analytical technologies for rapid assessment of adventitious agent contamination to improve the safety of cell therapy products.
- Singapore National Research Foundation
MIT Founding Co-Lead Principal Investigator
MIT Flagship Co-Captains
MIT Principal Investigators:
Assoc. Prof. Laurie Boyer
(Biology, Biological Engineering, Koch Institute for Integrative Cancer Research)